Clinical Trials Directory

Trials / Completed

CompletedNCT01645345

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

RF Pixel With Micro-Plasma Technology: Fractional Ablative Radiofrequency for the Treatment of Acne Scars and RF Pixel With Micro-Plasma Technology: Fractional Ablative Radiofrequency for the Treatment of Acne Scars and

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Alma Lasers Inc. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

To assess the safety and efficacy of the Pixel RF (fractional radio frequency) module in the treatment of acne scars and wrinkles.

Detailed description

The study design will be a prospective open label study. Up to 20 subjects of both genders with acne scars and/or wrinkles in the face will be recruited. The subjects will be treated once on clean acne scarred skin and three times on the the wrinkled skin with the Pixel RF handpiece. Each treatment duration will be approximately 30 minutes. The initial power and number of passes parameters shall be set according to the clinical indication and skin type of the subject treated (as well as the results of test sites). Clinical improvement will be assessed by the investigator physician from the visual appearance of the treated area according to the following scale: -1 for exacerbation, 0 no change, 1 for 1%-25% improvement, 2 for 25%-50% improvement, 3 for 50%-75% improvement, and 4 for 75%-99% improvement. Adverse side effects will be scored by clinical evaluation of erythema, edema, and burns. Real-time assessments will be made as well by the investigators. Treatment and results will be documented in a Case Report Form and follow-up sessions (1, 5 days after the treatment and 1 month and 3 months after the treatment).

Conditions

Interventions

TypeNameDescription
DEVICEAlma Lasers Accent RF Pixel handpieceTreatment with fractionated RF Pixel device

Timeline

Start date
2012-07-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-07-20
Last updated
2020-08-24

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01645345. Inclusion in this directory is not an endorsement.